Ads
related to: dior drug eluting balloon boston scientific lab analysis
Search results
Results From The WOW.Com Content Network
A drug-eluting stent (DES) is a small mesh tube that is placed in the arteries to keep them open in the treatment of vascular disease.The stent slowly releases a drug to block cell proliferation (a biological process of cell growth and division), thus preventing the arterial narrowing that can occur after stent implantation.
Shares of the medical device maker rose 1.5% in afternoon trading. The approval makes the device, branded Agent, the first drug-coated balloon catheter in the U.S. to treat coronary in-stent ...
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Polymer implant eluting drugs. Drug eluting implants encompass a wide range of bioactive implants that can be placed in or near a tissue to provide a controlled, sustained or on demand release of drug while overcoming barriers associated with traditional oral and intravenous drug administration, such as limited bioavailability, metabolism, and toxicity. [1]
PARIS — With the aim of reversing cellular aging, Parfums Christian Dior has entered into a research collaboration with Vadim N. Gladyshev, a professor of medicine at Brigham and Women’s ...
However, the stent has not completely done away with restenosis after angioplasty, and improved procedures continue to be sought. The drug-eluting stent, which releases chemicals that inhibit restenosis, has shown marked success and seems to be replacing the bare-metal stent in America, though Europeans have resisted the change due to the expense.
A 2014 meta-analysis showed there may be improved mortality with second generation drug-eluting stents, which were not available during the COURAGE trial. [52] Medical societies have since issued guidelines as to when it is appropriate to perform percutaneous coronary intervention.
Boston Scientific's Flextome is the most widely used cutting balloon. Cutting balloons have also been used in the treatment of refractory or recurrent laryngotracheal stenosis , particularly in cases where a dense ring of circumferential fibrosis has formed in the trachea or either bronchus '.